Decitabine + Cedazuridine OverviewDecitabine/cedazuridine, sold under the brand name Inqovi, is a fixed-dosed combination medication for the treatment of adults with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). It is a combination of decitabine, a nucleoside metabolic inhibitor, and cedazuridine, a cytidine deaminase inhibitor. The most common side effects of decitabine/cedazuridine ...
Read more Decitabine + Cedazuridine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Decitabine/cedazuridine
Recent Decitabine + Cedazuridine Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
Decitabine + Cedazuridine
- Tablet: 100mg + 35mg, 35mg + 100mg